Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 20/20 | 0.86 |
| ▸ | BCR | P11274 | 15/20 | 0.86 |
| ▸ | KIT | P10721 | 10/20 | 0.86 |
| ▸ | ABL2 | P42684 | 5/20 | 0.86 |
| ▸ | LYN | P07948 | 4/20 | 0.86 |
| ▸ | PDGFRA | P16234 | 3/20 | 0.86 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.86 |
| ▸ | SRC | P12931 | 2/20 | 0.86 |
| ▸ | SYK | P43405 | 2/20 | 0.86 |
| ▸ | PLK4 | O00444 | 1/20 | 0.86 |
| ▸ | DDX3X | O00571 | 1/20 | 0.86 |
| ▸ | GAK | O14976 | 1/20 | 0.86 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.86 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.86 |
| ▸ | CA12 | O43570 | 1/20 | 0.86 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.86 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.86 |
| ▸ | EGFR | P00533 | 1/20 | 0.86 |
| ▸ | CA1 | P00915 | 1/20 | 0.86 |
| ▸ | CA2 | P00918 | 1/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4667846 | 0.94 | ABL1 (0.83) | ABL1BCRKITABL2LYN | |
| Imatinib SCHEMBL2236091 | 0.92 | ABL1 (1.00) | ABL1BCRKITABL2LYN | |
| Imatinib SCHEMBL3827 | 0.92 | ABL1 (1.00) | ABL1BCRKITABL2LYN | |
| Imatinib SCHEMBL29351601 | 0.92 | ABL1 (1.00) | ABL1BCRKITABL2LYN | |
| Imatinib SCHEMBL29355523 | 0.92 | ABL1 (1.00) | ABL1BCRKITABL2LYN | |
| Imatinib SCHEMBL1977949 | 0.92 | ABL1 (0.98) | ABL1BCRKITABL2LYN | |
| Imatinib SCHEMBL15201213 | 0.92 | ABL1 (0.98) | ABL1BCRKITABL2LYN | |
| Imatinib SCHEMBL16431247 | 0.92 | ABL1 (0.98) | ABL1BCRKITABL2LYN | |
| Imatinib SCHEMBL3138052 | 0.92 | ABL1 (0.98) | ABL1BCRKITABL2LYN | |
| Imatinib SCHEMBL2929858 | 0.92 | ABL1 (0.98) | ABL1BCRKITABL2LYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111329863-A | Use of a composition containing a heterocyclic compound for the preparation of a medicament for the treatment of leukemia | 黄泳华 | 2020-06-26 | — | — | CN | claimed |
| CN-111298127-A | Composition comprising histamine release-promoting substance and inhibitory compound, and oral solid preparation containing the same | 黄泳华 | 2020-06-19 | — | — | CN | claimed |
| CN-110559443-A | composition comprising histamine release-promoting substance and pyridylpyrimidine amine compound, and oral solid preparation containing the same | 黄泳华 | 2019-12-13 | — | — | CN | claimed |
| CN-110559299-A | composition containing pyridyl pyrimidinamine compound and application thereof | 黄泳华 | 2019-12-13 | — | — | CN | claimed |
| CN-111329863-A | Use of a composition containing a heterocyclic compound for the preparation of a medicament for the treatment of leukemia | 黄泳华 | 2020-06-26 | — | — | CN | disclosed |
| CN-111298127-A | Composition comprising histamine release-promoting substance and inhibitory compound, and oral solid preparation containing the same | 黄泳华 | 2020-06-19 | — | — | CN | disclosed |
| CN-110559443-A | composition comprising histamine release-promoting substance and pyridylpyrimidine amine compound, and oral solid preparation containing the same | 黄泳华 | 2019-12-13 | — | — | CN | disclosed |
| CN-110559299-A | composition containing pyridyl pyrimidinamine compound and application thereof | 黄泳华 | 2019-12-13 | — | — | CN | disclosed |
| EP-1553948-A1 | COMBINATION OF A) N-(5(5-(4-METHYL-PIPERAZINO-METHYL)-BENZOYLAMIDO)-2-METHYLPHENYL)-4-(3-PYRIDYL)-2-PYRIMIDINE-AMINE AND B) A HISTONE DEACETYLASE INHIBITOR FOR THE TREATMENT OF LEUKEMIA | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2005-07-20 | — | — | EP | disclosed |